
Drug Substance Manufacturing - Mammalian Cell Cultures
Products
Information
Around 430,000 L total commercial capacity for cell culture Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors GMP facilities licensed by EMA, FDA, MHLW and other authorities All analytic capabilities inhouse GMP batch release testing Manufacturing of mAbs, recombinant enzymes, Fab fragments, Fc fusion proteins, TandAb, Ig DART, and further complex biologics like bi- or multispecific mAbs
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
All categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Contract ManufacturingBiomanufacturingProductsServices
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)
